{"disease":{"id":"skin-and-subcutaneous-tissue-bacterial-infections","name":"skin and subcutaneous tissue bacterial infections"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01170221","title":"TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":667,"lead_sponsor_name":"Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT01421511","title":"TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":666,"lead_sponsor_name":"Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT03964493","title":"TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"TenNor Therapeutics Limited","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}